Miglustat for treatment of Niemann-Pick C disease: a randomised
Por um escritor misterioso
Descrição
IJMS, Free Full-Text
PDF) Miglustat in Niemann-Pick disease type C patients: A review
New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat
Ocular motor biomarkers in Niemann-Pick disease type C: A prospective cross-sectional multicontinental study in 72 patients
Niemann-Pick disease type C
Miglustat in patients with Niemann-Pick disease Type C (NP-C): A
Treatment outcomes following continuous miglustat therapy in patients with Niemann-Pick disease Type C: a final report of the NPC Registry, Orphanet Journal of Rare Diseases
IJMS, Free Full-Text
Cyclodextrin Shows Promise in Niemann-Pick Type C Disease
The pathogenesis of Niemann–Pick type C disease: a role for autophagy?, Expert Reviews in Molecular Medicine
Efficacy and safety of arimoclomol in Niemann‐Pick disease type C: Results from a double‐blind, randomised, placebo‐controlled, multinational phase 2/3 trial of a novel treatment - Mengel - 2021 - Journal of Inherited
Niemann–Pick Disease Type C: Induced Pluripotent Stem Cell–Derived Neuronal Cells for Modeling Neural Disease and Evaluating Drug Efficacy - Daozhan Yu, Manju Swaroop, Mengqiao Wang, Ulrich Baxa, Rongze Yang, Yiping Yan, Turhan
de
por adulto (o preço varia de acordo com o tamanho do grupo)
